Improving the Health of Americans through Prevention and Management of Diabetes and Heart Disease and Stroke

 

The purpose of this program is to implement and evaluate evidence-based strategies to address the challenges and systemic barriers that contribute to prevention and management of cardiovascular disease and diabetes in high-burden populations. The Selection of high burden populations will be based on a robust analysis of diabetes and cardiovascular health burden across geographic areas and population subgroups. Population subgroups may be defined by factors such as race or ethnicity, gender, age [e.g. youth and older adults], education, income, disability, or sexual orientation, among others.

Active 93.426 Centers For Disease Control and Prevention, Department of Health and Human Services B - Project Grants Not applicable. Section 301(a) of the Public Health Service Act [42] U.S.C. Section 241(a) Title IV Section 4002 of the Affordable Care Action, Prevention and Public Health Fund
n/a State Governments or their Bona Fide Agents (includes the District of Columbia) are eligible Beneficiaries of this program include: State, Local, Individual/Family, Minority Group, Anyone/General Public, Black American, American Indian, Spanish Origin, Oriental, Other Nonwhite, Women, Handicapped, Physically Afflicted, Senior Citizen, Rural Not applicable. Preapplication coordination is required. This program is eligible for coverage under E.O. 12372, "Intergovernmental Review of Federal Programs." An applicant should consult the office or official designated as the single point of contact in his or her State for more information on the process the State requires to be followed in applying for assistance, if the State has selected the program for review. n/a 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards applies to this program. n/a Review and Selection Process: Applications will be reviewed in three phases. Phase I Review: All applications will be reviewed initially for completeness by CDC OGS staff and will be reviewed jointly for eligibility by the CDC National Center for Chronic Disease Prevention and Health Promotion and CDC OGS. Incomplete applications that do not meet the eligibility criteria will not advance to Phase II review. Phase II Review: This funding opportunity is comprised of two components - Component 1 and Component 2. Applications submitted under Component 1 are non-competitive and will support the implementation and evaluation of a core set of evidence-based strategies defined to reduce risk, complications, and/or barriers to prevent and control diabetes and cardiovascular disease among high-burden populations in all states and the District of Columbia. Applications submitted under Component 2 will be competitive and will support the implementation and evaluation of work on a small set of innovative strategies designed to reduce risks, complications, and/or barriers to prevent and control diabetes and prevention of heart disease and stroke. Component 2 applications will undergo an objective review panel process to evaluate complete and responsiveness according to the criteria section of the funding opportunity. Phase III Review: Applications submitted under Component 1 will be funded in accordance with the number of strategies selected by applicants from each of the diabetes and heart disease so that investments and outcomes may be clearly identified by funding line. Applications submitted under Component 2 will be funded in order by score and rank determined by the objective review panel. The Selecting official shall rely on the rank order established by the objective review panel as the primary factor in making awards. Contact the headquarters or regional location, as appropriate for application deadlines From 120 to 180 days. .Applications will be evaluated and approved or disapproved within 180 days of submission to the Federal Agency Not applicable. More than 180 days. .Renewals are contingent on availability of funds and are awarded for a 12 budget period within a 5 year project period. Review and Selection Process: Applications will be reviewed in three phases. Phase I Review: All applications will be reviewed initially for completeness by CDC OGS staff and will be reviewed jointly for eligibility by the CDC National Center for Chronic Disease Prevention and Health Promotion and CDC OGS. Incomplete applications that do not meet the eligibility criteria will not advance to Phase II review. Phase II Review: This funding opportunity is comprised of two components - Component 1 and Component 2. Applications submitted under Component 1 are non-competitive and will support the implementation and evaluation of a core set of evidence-based strategies defined to reduce risk, complications, and/or barriers to prevent and control diabetes and cardiovascular disease among high-burden populations in all states and the District of Columbia. Applications submitted under Component 2 will be competitive and will support the implementation and evaluation of work on a small set of innovative strategies designed to reduce risks, complications, and/or barriers to prevent and control diabetes and prevention of heart disease and stroke. Component 2 applications will undergo an objective review panel process to evaluate complete and responsiveness according to the criteria section of the funding opportunity. Phase III Review: Applications submitted under Component 1 will be funded in accordance with the number of strategies selected by applicants from each of the diabetes and heart disease so that investments and outcomes may be clearly identified by funding line. Applications submitted under Component 2 will be funded in order by score and rank determined by the objective review panel. The Selecting official shall rely on the rank order established by the objective review panel as the primary factor in making awards. Funds for this program are to be used to implement and evaluate evidence-based strategies to address the challenges and systemic barriers that contribute to prevention and management of cardiovascular disease and diabetes in high-burden populations. Performance Reports: Annual performance progress and monitoring reports will be expected from all awardees no later than 120 days prior to the end of each budget period. This report will serve as the continuation application for the follow-on budget period. The contents of the report should include the information specified in the solicitation from the CDC Grants Management Officer. Not applicable. CDC requires awardees to meet all record retention requirements defined in the notice of award, the funding opportunity, the HHS grants policy statement, and 45 CFR Part 75. Statutory formula is not applicable to this assistance listing.

Matching requirements are not applicable to this assistance listing.

MOE requirements are not applicable to this assistance listing. Funding for this program will be awarded on annual basis and the funding will be available for obligation by recipients for a period of 12-months. Method of awarding/releasing assistance: Lump. n/a Robert Hancock
4770 Buford Highway, MS F75
Atlanta, GA 30341 US
rnh2@cdc.gov
Phone: 7704887431 75-0943-0-1-550 (Project Grants) FY 18$90,000,002.00; FY 19 est $110,000,000.00; FY 20 est $110,000,000.00; FY 17$0.00; - This number supports funding from two division DDT and DHDSP . Awards ranged from $980,000 to $3,800,000. Awards we based on per-capita population and the burden of disease of diabetes and heart disease and stroke in each individual state. Not applicable. Not applicable.